As I pointed out, the company that used that flexibility in 2008 was extremely frustrated with the process, and the recent experience of Biolyse was not particularly different. Just getting a drug on schedule 1, as I said, takes several months, and the approach of going country to country and drug by drug is not really an efficient mechanism to respond to this crisis.
On April 4th, 2022. See this statement in context.